Mark Karshner - Orthopediatrics Corp Senior Sales

KIDS Stock  USD 26.47  0.97  3.80%   

Executive

Mark Karshner is Senior Sales of Orthopediatrics Corp
Address 2850 Frontier Drive, Warsaw, IN, United States, 46582
Phone574 268 6379
Webhttps://www.orthopediatrics.com

Orthopediatrics Corp Management Efficiency

The company has return on total asset (ROA) of (0.0394) % which means that it has lost $0.0394 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0763) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Asset Turnover is comparatively stable compared to the past year.
Orthopediatrics Corp currently holds 10.06 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Orthopediatrics Corp has a current ratio of 4.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Orthopediatrics Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

John WebbLivaNova PLC
N/A
Trui HebbelinckLivaNova PLC
52
Deanna WilkeLivaNova PLC
N/A
Bryan OlinLivaNova PLC
57
Gordon WeberSurModics
61
Sarah HuberPulmonx Corp
N/A
Matthew IIILivaNova PLC
N/A
Jennifer EnglundCVRx Inc
N/A
David LehmanPulmonx Corp
63
Brent LalomiaCONMED
49
Matthew LinkSight Sciences
Jonelle BurnhamCVRx Inc
53
Chad PattersoniRhythm Technologies
42
Ahmet TezelLivaNova PLC
N/A
Matt BrinckmanParagon 28
N/A
Chris CalcaterraGlaukos Corp
64
Julie AndrewsOrthofix Medical
53
Matthew BrinckmanParagon 28
N/A
Bradley NagelElectromed
42
Irene ThomasNeuropace
55
Sumi ShrishrimaliRhythm Technologies
45
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. Orthopediatrics Corp (KIDS) is traded on NASDAQ Exchange in USA. It is located in 2850 Frontier Drive, Warsaw, IN, United States, 46582 and employs 247 people. Orthopediatrics Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Orthopediatrics Corp Leadership Team

Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Daniel JD, General Legal
MBAMSHA CHE, President Technologies
Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources
Joel Batts, Senior Affairs
David Bailey, Executive Vice President
Mark Throdahl, President CEO, Director
Fred Hite, CFO, Director
Joseph Hauser, President Correction
Gregory Odle, Executive Vice President
Mark Karshner, Senior Sales

Orthopediatrics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Orthopediatrics Stock Analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.